SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-011359
Filing Date
2016-07-29
Accepted
2016-07-29 16:01:00
Documents
34
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_072916.htm 10-Q 167098
2 EXHIBIT 10.1 exh_101.htm EX-10.1 78858
3 EXHIBIT 10.2 exh_102.htm EX-10.2 26079
4 EXHIBIT 31.1 exh_311.htm EX-31.1 9264
5 EXHIBIT 31.2 exh_312.htm EX-31.2 9428
6 EXHIBIT 32 exh_32.htm EX-32 4489
  Complete submission text file 0001171843-16-011359.txt   1427698

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE caps-20160630.xml EX-101.INS 155020
8 XBRL SCHEMA FILE caps-20160630.xsd EX-101.SCH 21058
9 XBRL CALCULATION FILE caps-20160630_cal.xml EX-101.CAL 19677
10 XBRL DEFINITION FILE caps-20160630_def.xml EX-101.DEF 103691
11 XBRL LABEL FILE caps-20160630_lab.xml EX-101.LAB 137416
12 XBRL PRESENTATION FILE caps-20160630_pre.xml EX-101.PRE 119198
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21214 | Film No.: 161794143
SIC: 2834 Pharmaceutical Preparations